Related Experiment Video
Updated: Oct 4, 2026

Quantifying the Antifungal Activity of Peptides Against Candida albicans
Published on: January 13, 2023
Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal
M Lamberty1, A Caille, C Landon
1Institut de Biologie Moléculaire et Cellulaire, Unité Propre de Recherche 9022, CNRS, "Réponse Immunitaire et Développement chez les Insectes", 15 rue René Descartes, 67084 Strasbourg Cedex, France.
Abstract:
In response to an experimental infection, the lepidopteran Heliothis virescens produces an antifungal protein named heliomicin. Heliomicin displays sequence similarities with antifungal plant defensins and antibacterial or antifungal insect defensins. To gain information about the structural elements required for either antifungal or antibacterial activity, heliomicin and selected point-mutated variants were expressed in yeast as fusion proteins. The effects of mutations, defined by comparing the primary structure of heliomicin with the sequences of members of the insect defensin family, were analyzed using antibacterial and antifungal assays. One of the variants shows significant activity against Gram-positive bacteria while remaining efficient against fungi. The three-dimensional structures of this variant and of the wild-type protein were determined by two-dimensional (1)H NMR to establish a correlation between structure and antibacterial or antifungal activity. Wild-type and mutated heliomicins adopt a similar scaffold, including the so-called cysteine-stabilized alphabeta motif. A comparison of their structures with other defensin-type molecules indicates that common hydrophobic characteristics can be assigned to all the antifungal proteins. A comparative analysis of various structural features of heliomicin mutant and of antibacterial defensins enables common properties to be assessed, which will help to design new mutants with increased antibacterial activity.
Insights
Heliomicin, an antifungal protein from Heliothis virescens, was studied to understand its structural basis for activity. Mutations revealed a variant with enhanced antibacterial and retained antifungal properties, aiding future antimicrobial peptide design.
Area of Science:
- Molecular Biology
- Biochemistry
- Structural Biology
Background:
- The insect Heliothis virescens produces heliomicin, an antifungal protein with sequence similarities to plant and insect defensins.
- Understanding the structural determinants of heliomicin's activity is crucial for developing novel antimicrobial agents.
Purpose of the Study:
- To investigate the structural elements responsible for heliomicin's antifungal and antibacterial activities.
- To correlate structural modifications with changes in antimicrobial efficacy.
- To guide the design of new heliomicin variants with improved antibacterial properties.
Main Methods:
- Expression of wild-type heliomicin and point-mutated variants in yeast as fusion proteins.
- Antimicrobial assays (antibacterial and antifungal) to evaluate the activity of protein variants.
- Three-dimensional structure determination of wild-type and a potent variant using 2D (1)H NMR spectroscopy.
Main Results:
- A heliomicin variant demonstrated significant activity against Gram-positive bacteria while maintaining antifungal efficacy.
- Both wild-type and mutated heliomicins share a common cysteine-stabilized alpha/beta scaffold.
- Structural comparison revealed common hydrophobic characteristics in antifungal defensins and identified features associated with antibacterial activity.
Conclusions:
- Structural analysis of heliomicin variants provides insights into the structure-activity relationships of insect defensins.
- The study facilitates the rational design of novel antimicrobial peptides with tailored activity spectra.
- Targeted mutations can enhance the antibacterial potency of heliomicin while preserving its antifungal function.
Related Concept Videos
Antifungal Agents
Anthelminthic Agents
Antiviral Nucleoside Inhibitors
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antiprotozoal Agents
Production of Antibiotics

